论文信息 - Patient‐reported health‐related quality of life from the phase III TOURMALINE‐MM1 study of ixazomib‐lenalidomide‐dexamethasone versus placebo‐lenalidomide‐dexamethasone in relapsed/refractory multiple myeloma - 字舞流文

Patient‐reported health‐related quality of life from the phase III TOURMALINE‐MM1 study of ixazomib‐lenalidomide‐dexamethasone versus placebo‐lenalidomide‐dexamethasone in relapsed/refractory multiple myeloma

C. Cleeland | P. Richardson | P. Moreau | X. Leleu | C. Langer | T. Masszi | L. Rosiñol | T. Izumi | P. Gimsing | O. Samoilova | N. Bahlis | K. Song | T. Skácel | D. Berg | H. Lin | V. Maisnar | Yanyan Zhu | B. Baker | L. Viterbo